Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-02-14 12:38 pm Sale | 13G | ACADIA Pharmaceuticals Inc. ACAD | PRICE T ROWE ASSOCIATES INC | 4,279,254 2.6% | -5,207,007 (-54.89%) | View |
| 2023-02-09 10:54 am Purchase | 13G | ACADIA Pharmaceuticals Inc. ACAD | VANGUARD GROUP INC | 13,279,775 8.2% | 964,409 (+7.83%) | View |
| 2023-02-09 08:23 am Sale | 13G | ACADIA Pharmaceuticals Inc. ACAD | FMR LLC | 9,334,613 5.764% | -4,506,137 (-32.56%) | View |
| 2023-01-31 5:52 pm Purchase | 13G | ACADIA Pharmaceuticals Inc. ACAD | BlackRock Inc. BLK | 10,258,738 6.3% | 198,426 (+1.97%) | View |
| 2023-01-17 4:32 pm Purchase | 13D | ACADIA Pharmaceuticals Inc. ACAD | BAKER BROS. ADVISORS LP | 42,306,789 26.1% | 1,138,932 (+2.77%) | View |
| 2022-02-14 2:34 pm Purchase | 13G | ACADIA Pharmaceuticals Inc. ACAD | PRICE T ROWE ASSOCIATES INC | 9,486,261 5.9% | 1,608,436 (+20.42%) | View |
| 2022-02-09 3:15 pm Purchase | 13G | ACADIA Pharmaceuticals Inc. ACAD | VANGUARD GROUP INC | 12,315,366 7.66% | 1,709,593 (+16.12%) | View |
| 2022-02-09 09:09 am Sale | 13G | ACADIA Pharmaceuticals Inc. ACAD | FMR LLC | 13,840,750 8.609% | -5,632,163 (-28.92%) | View |
| 2022-02-04 4:12 pm Purchase | 13G | ACADIA Pharmaceuticals Inc. ACAD | BlackRock Inc. BLK | 10,060,312 6.3% | 2,302,466 (+29.68%) | View |
| 2021-02-16 12:23 pm Sale | 13G | ACADIA Pharmaceuticals Inc. ACAD | PRICE T ROWE ASSOCIATES INC | 7,877,825 4.9% | -5,363,189 (-40.50%) | View |
| 2021-02-10 10:30 am Sale | 13G | ACADIA Pharmaceuticals Inc. ACAD | VANGUARD GROUP INC | 10,605,773 6.67% | -10,840 (-0.10%) | View |
| 2021-02-08 10:15 am Sale | 13G | ACADIA Pharmaceuticals Inc. ACAD | FMR LLC | 19,472,913 12.248% | -1,418,004 (-6.79%) | View |
| 2020-07-10 10:39 am Sale | 13G | ACADIA Pharmaceuticals Inc. ACAD | BlackRock Inc. BLK | 7,757,846 4.97% | -2,481,049 (-24.23%) | View |
| 2020-02-14 1:30 pm Purchase | 13G | ACADIA Pharmaceuticals Inc. ACAD | PRICE T ROWE ASSOCIATES INC | 13,241,014 8.5% | 7,582,717 (+134.01%) | View |
| 2020-02-12 11:08 am Purchase | 13G | ACADIA Pharmaceuticals Inc. ACAD | VANGUARD GROUP INC | 10,616,613 6.89% | 474,949 (+4.68%) | View |
| 2020-02-07 11:12 am Sale | 13G | ACADIA Pharmaceuticals Inc. ACAD | FMR LLC | 20,890,917 13.563% | -652,976 (-3.03%) | View |
| 2020-02-05 11:25 am Purchase | 13G | ACADIA Pharmaceuticals Inc. ACAD | BlackRock Inc. BLK | 10,238,895 6.6% | 105,429 (+1.04%) | View |
| 2019-09-20 4:48 pm Purchase | 13D | ACADIA Pharmaceuticals Inc. ACAD | BAKER BROS. ADVISORS LP | 41,167,857 27.1% | 1,243,368 (+3.11%) | View |
| 2019-02-14 2:45 pm Sale | 13G | ACADIA Pharmaceuticals Inc. ACAD | Point72 Asset Management L.P. | 2,251,978 1.6% | -4,269,588 (-65.47%) | View |
| 2019-02-13 11:44 am Purchase | 13G | ACADIA Pharmaceuticals Inc. ACAD | FMR LLC | 21,543,893 14.999% | 2,913,048 (+15.64%) | View |